We found that components of the novel NOX2/Egr-1/Fyn pathway were also commonly up-regulated in EGFR-expressing patient GBM patient samples (Figure 5A) and cell line models (Figure 5B and 5C), where they remained dependent on p47phox (Figure 5I). This evidence concerns the gene EGR1 and glioblastoma.